Paradigm Spine Receives FDA Approval for Spinal Stenosis Device

Paradigm Spine has won FDA premarket approval for its coflex device, a minimally invasive motion-preserving interlaminar stabilization device for spinal stenosis.

Advertisement

A six-year clinical trial of coflex shows shorter hospital stays, faster procedures and improved pain and function compared to patients who underwent pedicle screw fusions.

More Articles on Orthopedic Devices:

Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B

Brian McCollum to Lead Orthofix Spine Global Business Unit

Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.